Journal Highlights

JPET Highlight: Strontium is a Biased Agonist of the Calcium-Sensing Receptor

Posted on 11/15/2012 5:28:18 PM

The calcium-sensing receptor specific allosteric modulator, cinacalcet, is used to treat secondary hyperparathyroidism in patients with chronic kidney disease. Due to hypocalcemic side effects, clinical application is limited. The results of the present study suggest that calcitonin secretion can be affected by CaSR-stimulated signaling bias. See article at J Pharmacol Exp Ther 2012, 343:638–649. (JPET 197210)

Comments (0)


Leave a comment


Blog comments are moderated and will be posted once approved.

Name


Comment:



Enter the code shown above:


 

Support the Abel Fund 

Annual Meeting Program button 

PharmTalk Blog 

President's Blog